Skip to content

Travere Therapeutics, Inc. TVTX Change in Inventories

Change in Inventories at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$97.7M-41.5%
LQD
Liquidia CorporationLQDA
$4.57M+312%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$4M+300%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$7.05M+121%
PTC Therapeutics logo
PTC TherapeuticsPTCT
-$2.64M-20.6%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
-$2.24M-1,043%

Other financials

Income statement

See full
Revenue$127.2M+55.6%
Gross profit$125.2M+62.5%
Operating income-$36.9M+13.5%
Net income-$37.1M+10.0%
EPS (diluted)-$0.40+14.9%

Balance sheet

See full
Cash & equivalents$78.4M+26.6%
Total debt$15.6M-82.6%
Total equity$98.7M+201%
Total assets$555.2M+1.2%

Cash flow

See full
Operating cash flow-$40.4M+4.3%
CapEx$140.0K
Free cash flow-$42.5M+28.1%

Valuation

See full
Market cap$5.2B+72.3%

Profitability

See full
Gross margin98.6%+2.6pp
Operating margin-10.6%-5.0pp
Net margin-20.3%-9.5pp
FCF margin-133.9%-34.4pp

Returns & leverage

See full
Return on equity-706%-1,302pp
Debt / equity0.2×-2.6×
Current ratio3.1×+1.1×

Where this comes from

Reported directly by Travere Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Travere Therapeutics, Inc.'s change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Travere Therapeutics, Inc.'s change in inventories?
Travere Therapeutics, Inc. (TVTX) reported change in inventories of $742K in Q1 2026.
How has Travere Therapeutics, Inc.'s change in inventories changed year-over-year?
Travere Therapeutics, Inc.'s change in inventories increased by 120.3% year-over-year, from -$3.66M to $742K.
What is the long-term trend for Travere Therapeutics, Inc.'s change in inventories?
Over 3 years (2021 to 2025), Travere Therapeutics, Inc.'s change in inventories has grown at a 250.4% compound annual growth rate (CAGR), from -$117K to -$5.04M.
What does change in inventories mean?
Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.